News
2021 Randy Shaver Cancer Research & Community Fund Awards
Each year the Randy Shaver Cancer Research & Community Fund awards grants to groups across the state of Minnesota that are working to reduce the burden of cancer.
The mission of the Randy Shaver Cancer Research and Community Fund is…
Advances in cell biology help understanding human cancer and neurodegeneration.
For the longest time, cancer and neurodegenerative diseases have been considered at the opposite end of the spectrum of human diseases. That is because cancer is characterized by highly dividing cells that resist death while…
Hormel Institute Scientist Awarded ~$4Million for Leukemia Research
Dr. Shujun Liu research will focus on new target to control leukemia
Breakthrough research linking breast cancer to diet
AUSTIN, Minn – January 11, 2021 – Dr. Leena Hilakivi-Clarke, head of the Women’s Health research section at The Hormel Institute, University of Minnesota, published new research into dietary modifications that could lead to reduced breast…
U of M begins Phase I of first-in-human clinical trial for glioblastoma
MINNEAPOLIS, MN - January 7, 2021 - Physicians and scientists at the University of Minnesota have opened a new brain cancer clinical trial and have treated their first patient. This Phase I, first-in-human trial is enrolling patients with…
Talking cervical cancer awareness with U of M
January is National Cervical Cancer Awareness Month. The American Cancer Society estimates there were 140 new cases of cervical cancer in Minnesota in 2020.
Deanna Teoh with the University of Minnesota answers questions on…
U of M opens iPSC-derived CAR NK cell trial for patients with Non-Hodgkin Lymphoma as consolidation after an autologous transplant
MINNEAPOLIS, MN - The University of Minnesota is pioneering a novel therapeutic approach to improve the curative potential of hematopoietic stem cell transplantation for patients with Non-Hodgkin Lymphoma that are at high risk of relapse.…
A study out of the University of Minnesota is showing the killer instinct found in natural killer cells
Researchers at the Masonic Cancer Center, University of Minnesota have developed a system to produce and expand natural killer (NK) cells derived from human-induced pluripotent stem cells (iPSC). These manufactured NK cells were shown as…
U of M opens first-in-class engineered NK cell therapy trial for the treatment of patients with advanced multiple myeloma and leukemia
The University of Minnesota has become the first location in the world for a new innovative clinical trial for the treatment of acute myelogenous leukemia (AML) and multiple myeloma. The Phase 1 clinical trial for FT538 will eventually be…